NIH asks whether clinical-trial participants should receive plain-language study results

The National Institutes of Health is asking for public comment on a draft policy that would generally require researchers to share plain-language summaries of overall study results with participants in NIH-supported clinical research.

NIH released the request for information on August 27, 2026. Comments are due October 26, 2026. The proposal is a draft, not a final rule or currently binding requirement.

What NIH is proposing

The draft would cover clinical research supported in whole or in part by NIH, regardless of the funding level or mechanism. That includes clinical trials, other covered clinical research conducted outside NIH and research carried out through the NIH Intramural Research Program.

Researchers and institutions generally would have to share a concise, summary-level account of the study in language that is clear, organized and appropriate to the research topic, culture and context. The proposed summaries could cover the study’s objective, methods, cumulative findings, limitations, relevance and potential implications.

The policy concerns aggregate study results, not individualized medical findings such as a participant’s personal laboratory results or other participant-specific health information. NIH describes those as separate categories of research results.

Researchers would also have to offer participants the results, whether or not participants ultimately receive them. If unforeseen circumstances made sharing no longer possible, the draft would require researchers to tell participants and explain why. An exception could be requested when sharing is justifiably inappropriate, but the request would generally need NIH Institute, Center or Office approval.

When sharing would occur

For clinical trials, the proposed deadline would generally be the later of one year after the study’s primary completion date or the applicable deadline for reporting results through ClinicalTrials.gov.

For extramural clinical research that is not a clinical trial, researchers would generally share the summary by the end of the project’s period of performance if the analyses needed to complete it are finished. If the analyses are not complete, the draft would require a status update to NIH and participants explaining when, where and how the results are expected to be provided.

For NIH intramural clinical research, investigators would provide annual status updates to participants about when, where and how results will be shared, beginning no later than six months after the policy’s effective date.

How this differs from ClinicalTrials.gov

The proposed policy would supplement, not replace, existing public reporting requirements. ClinicalTrials.gov is the federal public system for information about clinical studies, and covered trials remain subject to applicable registration and results-reporting obligations.

The draft addresses a different communication channel: an understandable summary offered directly to people who took part in the research. NIH says existing transparency efforts have largely focused on public and scientific reporting, while direct communication with participants has not been consistent across the research enterprise.

Who could be affected

The policy could affect universities, hospitals, research organizations, contractors and other recipients of NIH support, along with researchers working on covered NIH intramural projects. Participants in those studies could eventually have a formal opportunity to receive a plain-language explanation of the collective findings.

NIH says the requirement would be included in applicable award terms, agreements and intramural policies. Recipients would have to confirm to NIH that results were shared or that a status update was provided. For extramural institutions, the draft says that confirmation would occur in the Research Performance Progress Report during closeout.

Failure to comply could support enforcement actions, including additional special terms and conditions or termination, subject to applicable grant, acquisition and NIH rules. Those consequences are part of the draft framework; they do not mean the proposed policy is already enforceable.

What remains unsettled

NIH is still seeking input on what summaries should contain, how they should be delivered and how participant preferences, accessibility, language and cultural needs should be handled. The agency is also asking about tools, staffing, costs and other resources needed to carry out the policy without unnecessary administrative burden.

The draft would apply to specified new competing applications, revisions, contracts, orders and other funding agreements received six months after publication of a final policy. It would also apply to NIH intramural clinical research conducted six months after publication of a final policy, including ongoing or new studies within the draft’s stated scope. It would not immediately impose the requirement on every ongoing NIH-supported study.

Participants, researchers, clinicians, institutions and advocacy groups may submit comments through NIH’s online process by October 26, 2026. The final policy, any approved exceptions and later supplemental guidance will determine what summaries must contain, how they are delivered and how researchers document compliance.

Sources

Look for updates to this story

Discover more from Interactive News

Subscribe to get the latest posts sent to your email.